Share

    


In This Section

Home / Advocate / Letters and Statements

Letters and Statements

ACCC writes and signs on to letters to Congress and the Administration to promote our policy interests. We also write advocacy statements, blog posts, and opinion pieces on a wide range of topics in cancer care. Questions related to health policy? Contact Nicole Tapay, JD, Director, Cancer Care Delivery & Health or Meagan O’Neill, MS, Executive Director of ACCC.

Follow ACCC (@ACCCBuzz) on Twitter for late-breaking cancer policy news and announcements.

Latest Letters

  • ACCC Expresses Concern to FDA Regarding Inspection Delays
    October 11, 2022

    In a letter to U.S. Food and Drug Administration (FDA) Commissioner Robert Califf, M.D., ACCC raises concern about recent delays in inspections of manufacturing facility that have led to interruptions in the approval of breakthrough therapies. We are particularly concerned when these delays impact novel treatments for diseases without FDA-approved therapies available and those that disproportionately impact minority communities.
    Read the Letter

Advocacy News Releases

  • ACCC Statement on Chemotherapy Drug Shortages

    Jun 14, 2023

    The Association of Community Cancer Centers (ACCC) is highly concerned about the ongoing shortages of platinum-based chemotherapy agents (e.g., cisplatin and carboplatin), two medications that (individually or in combination) treat and cure a wide range of cancers, including but not limited to gastric, pancreatic, colorectal, esophageal, cervical, and ovarian.

  • ACCC Statement on the Enhancing Oncology Model

    Jun 29, 2022

    The Association of Community Cancer Centers (ACCC) is pleased that the Centers for Medicare & Medicaid Services (CMS) has announced a new, voluntary alternative payment model as a successor to the Oncology Care Model (OCM), which is due to sunset later this month.

  • Leading Oncology Professionals Meet with Capitol Hill Lawmakers to Advocate for Improved Access to Cancer Care

    Jun 15, 2022

    Multidisciplinary cancer care leaders, including physicians, nurses, pharmacists, program administrators, social workers, financial advocates, and patient navigators, from all across the country are meeting with congressional offices today to advocate for policies that support their patients as part of the Association of Community Cancer Centers’ (ACCC) 2022 Virtual Hill Day.

  • ACCC Principles to Preserve Provider and Patient Choice in Cancer Treatment

    Apr 29, 2022

    Health plans and pharmacy benefit managers should find ways to support treatment decisions made by cancer care providers and their patients rather than limiting where, how, and which drugs can be administered.

Read All News Releases